Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / MIST - Milestone Pharma provides update on Etripamil program in PSVT

MIST - Milestone Pharma provides update on Etripamil program in PSVT

Milestone Pharmaceuticals Inc.
  • Milestone Pharmaceuticals (MIST) Q2 results: Revenues: $0; R&D Expense: $10.5M; SG&A: $1.6M; Net loss: ($13.7M); loss/share: ($1.04) (+91.8%); Quick Assets: $145.8M (+69.5%).
  • More news on: Milestone Pharmaceuticals Inc., Healthcare stocks news, Earnings news and commentary,
    • Read more ...
Stock Information
Company Name: Milestone Pharmaceuticals Inc.
Stock Symbol: MIST
Market: NASDAQ
Website: milestonepharma.com
Menu
MIST MIST Quote MIST Short MIST News MIST Articles MIST Message Board
Get MIST Alerts

News, Short Squeeze, Breakout and More Instantly...